[1] | Wentao XIE, Kangkang YU, Qi CHENG, Ning LI. Mechanism of microRNA-223-3p inhibiting hepatic stellate cell activation by targeting microtubule-associated protein 1B[J]. Journal of Clinical Hepatology, 2023, 39(12): 2845-2850. doi: 10.3969/j.issn.1001-5256.2023.12.015 |
[2] | Xiang XiaoHui, Mao Jun, Li Hai. Expression and clinical significance of CCDC34 in hepatocellular carcinoma:An analysis based on The Cancer Genome Atlas database[J]. Journal of Clinical Hepatology, 2020, 36(5): 1050-1054. doi: 10.3969/j.issn.1001-5256.2020.05.020 |
[3] | Mao Jun, Li RenLi, Li Hai, Xia ShiHai, Zhang WenCheng, Xiang XiaoHui. Expression and clinical significance of ZNF580 mRNA in hepatocellular carcinoma: An analysis based on The Cancer Genome Atlas database[J]. Journal of Clinical Hepatology, 2019, 35(10): 2231-2235. doi: 10.3969/j.issn.1001-5256.2019.10.020 |
[4] | Tang Ling, Qiu LuDie, Qin Wen, Wu Gang. Expression of circular RNA FLI1 in patients with hepatocellular carcinoma and its association with prognosis[J]. Journal of Clinical Hepatology, 2019, 35(9): 1980-1984. doi: 10.3969/j.issn.1001-5256.2019.09.019 |
[5] | Huang XiangJun, Zhang WenXing. Expression features and clinical significance of the microRNA-888 gene family in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(1): 119-122. doi: 10.3969/j.issn.1001-5256.2019.01.022 |
[6] | Liang RunWei, Fan ZhengJun, Huang Juan, Sun Tao, Yu ZuQi. Expression and clinical significance of protein kinase CK2β in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(3): 547-552. doi: 10.3969/j.issn.1001-5256.2019.03.019 |
[7] | Li ZhangXin, Zhou Tao, Niu KeMin, Chen Jing, Wei BeiHai, Wang Jia, Meng SiHong, Li QinNa, Zheng Jiao, Shen QingYan, Chen RuiLin. Effect of liver-regulating and spleen-strengthening method on lipid metabolism and expression of microtubule-associated protein light chain 3B in a rat model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(4): 829-835. doi: 10.3969/j.issn.1001-5256.2018.04.027 |
[8] | Lei GuangLin, Wang Quan, Cheng SiJie, Lai ChengCai, Wang KeYu, Yan Jin, Yang PengHui, Zhang ShaoGeng. Expression of the long non-coding RNA XLOC-007123 in hepatitis B-related hepatocellular carcinoma and its clinical significance[J]. Journal of Clinical Hepatology, 2018, 34(2): 309-313. doi: 10.3969/j.issn.1001-5256.2018.02.018 |
[9] | Fan Bin, Zhang Yong, Li JinMao, Liu Tao, Zhang JiaYao. Association between the expression of centromere protein F and prognosis in patients with hepatocellular carcinoma:An analysis using GEO database[J]. Journal of Clinical Hepatology, 2018, 34(7): 1475-1480. doi: 10.3969/j.issn.1001-5256.2018.07.022 |
[10] | He ZeLing, Cao JianBiao, Fan GongRen. Expression and role of heat shock protein 70 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(11): 2206-2209. doi: 10.3969/j.issn.1001-5256.2016.11.047 |
[11] | Bai LiQing, Qiao JiaNi. Expression and correlation analysis of γ-glutamyl transpeptidase and alpha-fetoprotein in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(9): 1452-1454. doi: 10.3969/j.issn.1001-5256.2015.09.021 |
[12] | Wang JianGang, Fei XinYing, Song Qing. Application of proteomics in study of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 958-960. doi: 10.3969/j.issn.1001-5256.2014.09.030 |
[13] | Gao Chun, Fang Long, Yao ShuKun. Correlation of GGT with AFP and diagnostic value of GGT for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 921-925. doi: 10.3969/j.issn.1001-5256.2014.09.021 |
[14] | Xi PengCheng, Shi KaiWang, Zhu Xiang, Yang KunXing, Liu ZiJun, Bian JianMin, Zhao YouCai. Analysis of clinical significance of quantitative expression of VEGF mRNA and uPA mRNA in pancreatic cancer tissue[J]. Journal of Clinical Hepatology, 2014, 30(8): 752-756. doi: 10.3969/j.issn.1001-5256.2014.08.014 |
[15] | Ye Chao, Chen YongPing, Dai ZhiJuan, Li WenYuan, Lin Zhuo, Cheng Yuan, Jin XiaoZhi. Dynamic expression of β-catenin in rat models of hepatic fibrosis and its significance[J]. Journal of Clinical Hepatology, 2011, 27(3): 261-264. |
[16] | Li Hui, Zhang Ting, Lu FengMin, Xu ChunHui, Tang FuAi, Chen XiangMei, Ma Jun. Associated expression of Plkl and p21WAF1/CIP1 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(4): 394-396. |
[17] | Zhang HaiJian, Yao DengFu, Qin ChengLin. The role of annexin A2 overexpression in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(7): 772-774+778. |
[18] | Li HaiPing, Tao JianShu, Gao Bo, Yu ZongTao, Li WenCui, Zhang JiCai. The expression and clinical significance of resistance gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(9): 972-975. |
[19] | Chen LiDong, Cheng Jun, Hong Yuan, Zhang LianFeng, Han Li, Guo Jiang. Construction of the prokaryotic expression vector of NS5ATP4A gene and its expression[J]. Journal of Clinical Hepatology, 2010, 26(4): 371-373. |
[20] | Lu DongDong, Zhang XiRan. The primary study of expression and function of CK2α subunit in liver cancer[J]. Journal of Clinical Hepatology, 2003, 19(4): 240-241. |